The medication for the treatment of liver diseases and biliary tract

Consumers survey results of 2014 in category

Digestive system and hepatology / The medication for the treatment of liver diseases and biliary tract

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	2	Hepabene (ratiopharm)	38.30%	5

2.	1	Essentiale Forte N (Sanofi)	38.30%	4.60

3.	4	Алохол (Борщагівський ХФЗ)	25.53%	3.66

4.	3	Карсил (Sopharma)	27.66%	3.56

5.	6	Галстена (Perrigo)	21.28%	2.38

6.	5	Chophytol (Lab. Rosa-Phytopharma)	14.89%	2.03

7.	~	Холагол (Teva)	8.51%	1.29

8.	6	Енерлів (Berlin-Chemie Menarini)	6.38%	1.16

9.	17	Лів.52 (Фірма ТК Комфорт)	6.38%	1.01

10.	7	Antralum (Farmak)	6.38%	0.97

10.	11	Гепа-Мерц (Merz Pharmaceuticals)	10.64%	0.97

12.	10	Дарсіл (Darnitsa)	4.26%	0.87

12.	8	Холосас (Vitaminy)	4.26%	0.87

–.	18	~~Артишока екстракт Гексал (Sandoz)~~	~~4.26%~~	~~0.79~~

14.	18	Фламін (Arterium Corporation)	6.38%	0.59

–.	20	~~Гепалекс (Sandoz)~~	~~2.13%~~	~~0.50~~

15.	19	Гепафорте (Bosnalijek)	2.13%	0.50

15.	9	Легалон (Madaus)	2.13%	0.50

15.	13	Ліволін Форте (Mega Lifesciences)	2.13%	0.50

15.	~	Цінарікс (Montavit)	2.13%	0.50

19.	18	Гепатофіт (Aim)	2.13%	0.30

19.	14	Есслівер Форте (Stada)	4.26%	0.30

21.	13	Силібор (Pharmaceutical company “Zdorovya”)	2.13%	0.15

–.	19	~~Силімарин Гексал (Sandoz)~~	~~2.13%~~	~~0.15~~

21.	~	Холензим (Belmedpreparaty)	2.13%	0.15

21.	19	Холівер (Hau Giang Ph. JSK-HG Pharm)	2.13%	0.15

–.		Febichol (Noventis)	0.00%	0

–.		Raphacholin C (Herbapol)	0.00%	0

–.	12	Артіхол (Київський вітамінний завод)	0.00%	0

–.	20	Берези бруньки (Ternopharm)	0.00%	0

–.	18	~~Биликур (Sandoz)~~	~~0.00%~~	0

–.		Бонджигар (Herbion)	0.00%	0

–.		Бренціале Форте (Бринцалов-А)	0.00%	0

–.		Гепарсил (Стиролбіофарм)	0.00%	0

–.		Гепато-флора (Медіфлора)	0.00%	0

–.		Глутаргін (Pharmaceutical company “Zdorovya”)	0.00%	0

–.		Левасіл (Micro Labs)	0.00%	0

–.	16	Нукс Воміка (Heel)	0.00%	0

–.		ПМ Сірін (N. Kapharma Pharmaceuticals)	0.00%	0

–.		Силімарол (Євролек)	0.00%	0

–.		Симепар (Teva)	0.00%	0

–.		Фосфоліп (Universal Medicare)	0.00%	0

–.	15	Холе-гран (Національна гомеопатична спілка)	0.00%	0

–.		Холензим (Біосинтез)	0.00%	0

–.	18	Цитраргінін (Zambon France)	0.00%	0

The participant which took the 1st place in this rating is by opinion of Ukrainian consumers is the best choice in 2014, recommendation of consumers #1 in the category “The drug for the treatment of liver diseases and biliary tract”.

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2014, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.